All Upcoming Events

In this webinar, leading oncology experts Dr. Javier Cortés and Dr. Antonio Llombart-Cussac will explore how collaborative-initiated trials are transforming the clinical research landscape and creating new opportunities for scientific and clinical impact.

DIA’s Medical Affairs and Scientific Communications Forum brings together medical affairs professionals to share best practices, tackle current challenges, and drive innovation in healthcare communication. What to Expect: Three specialized tracks: medical communications, medical writing, and field medical Roundtable discussions and real-world case studies you can apply immediately Poster sessions featuring original research DIA Community Meet-ups and networking receptions Exhibit hall showcasing innovative technologies and solutions Why Attend: Connect with like-minded professionals, gain practical insights on regulatory compliance and strategic communications, and build cross-functional relationships that enhance your impact. Designed by medical affairs practitioners, for practitioners.

Artificial intelligence is rapidly reshaping the life sciences, from automating repetitive tasks to enabling advanced scientific and safety assessments across drugs, biologics, and devices. As adoption grows across regulators, pharmaceutical companies, technology developers, nonprofits, and collaborative consortia, the need for clear, risk-based frameworks for validation, governance and human oversight becomes increasingly critical.

Enable confident, data-driven R&D investment decisions through modern governance, AI-powered insights, and cross-functional alignment.

Every biopharma R&D and investment decision could be guided by connected intelligence. Join us to hear firsthand how agentic workflows and enterprise-scale data are helping drug developers move faster from molecule to market with greater confidence.

Navigating AI, Globalization, and Integration while Demonstrating Strategic Value

hubXchange’s Antibody Therapeutics Xchange Boston 2026 brings together senior scientists and executives from leading pharma and biotech companies for a highly interactive, discussion-driven meeting focused on advancing next-generation antibody therapeutics. The event features expert presentations, roundtables, 1:1 meetings, and networking sessions covering target selection, lead optimization, multispecific engineering, and ADC innovation. Designed to foster collaboration and accelerate discovery, this one-day forum offers valuable insights from top industry leaders. Join us in Boston on April 28, 2026

Step into a room full of the people shaping the future of biologics at the Antibody Manufacturing Xchange Boston 2026. This one-day, invitation-only forum brings together senior experts across Cell Line Development, Upstream and Downstream Processing, Formulation, and Quality Control to tackle the real-world challenges of scaling and optimizing antibody production. Through focused discussions, expert insights, and high-value networking, you’ll gain practical solutions, new collaborations, and fresh perspectives to accelerate manufacturing efficiency and product quality. If driving better, faster, more reliable antibody manufacturing is on your agenda, this is the event you won’t want to miss.

The Oligonucleotides & Peptides Xchange Boston 2026 is a one-day, invitation-level forum for senior scientists and executives in pharma and biotech, focused on accelerating the development of oligonucleotide and peptide therapeutics. Through interactive roundtables, expert talks, 1:1 meetings, poster sessions, and networking, we will tackle key challenges across discovery, delivery, CMC, and quality control. The event is designed for collaboration and innovation — and registration is complimentary for qualified delegates. Join us in Boston on April 30, 2026.

USAIC has created an ecosystem committed to driving a global dialogue on BioPharma & Healthcare innovation, attracting a diverse mix of senior industry professionals and catalyzing partnerships, new ideas, networks and regulatory reform.

Advanced Therapies Xchange Boston 2026 brings together senior leaders from pharma and biotech for a highly interactive, one-day forum focused on accelerating cell and gene therapy innovation. Featuring expert presentations, roundtable discussions, 1:1 meetings, and networking, the event explores next-generation vector engineering, cell therapy development, and scalable gene therapy manufacturing. Registration is complimentary for qualified delegates. Join us on May 4, 2026 in Boston.

Join leading scientists and innovators at the CNS Discovery Xchange Boston 2026 — a high-energy, one-day forum designed to spark collaboration and accelerate breakthroughs in CNS drug discovery. Across five focused tracks—Biomarkers, Target Discovery, Disease Models, Novel Modalities, and BBB/Drug Delivery—you’ll explore the latest science, debate new approaches, and gain insights you can apply immediately to your CNS pipeline. With interactive roundtables, expert talks, targeted 1:1 meetings, and exceptional networking, this is where meaningful connections and actionable ideas come together. If you’re working to advance CNS therapeutics, this is the room you need to be in.

hubXchange’s AI in Drug Discovery Xchange Boston 2026 convenes senior-level scientists and biotech/pharma executives to explore how AI is transforming drug discovery. The one-day, highly interactive event includes roundtable discussions, 1:1 meetings, expert presentations, poster sessions and networking — diving into critical topics like data quality, target identification, lead generation & optimization, drug response prediction, and drug design & modeling. Join peers and industry experts in Boston on May 6, 2026 to collaborate, share insights, and accelerate AI-driven drug discovery efforts.

The AAPS National Biotechnology Conference uncovers the trends driving today’s research and biopharma markets. Join leading pharmaceutical scientists May 11-14, in San Diego, CA, for sessions covering new modalities and novel strategies in biotherapeutic development.

The ASCO Annual Meeting is The Place to Be. With a tradition of inspiring and advancing the oncology field, this must-attend event promises to deliver an experience that cannot be found anywhere else.

The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe.

Catalysis 2026 conference will serve as a multidisciplinary platform to discuss novel materials and reaction systems, advanced catalytic mechanisms, reactor design, and computational approaches that are driving transformative progress in catalysis. Topics of focus will include but are not limited to: 1. Homogeneous and heterogeneous catalysis 2. Biocatalysis and enzyme engineering 3. Photocatalysis and electrocatalysis 4. Nanocatalysts and advanced catalyst materials 5. Process intensification and green chemistry 6. Catalysis for energy, fuels, and environmental applications 7. Industrial catalysis and scale-up challenges